Table 3.
Clinical and radiological outcomes. aSAH aneurysmal subarachnoid hemorrhage, npmSAH non-perimesencephalic SAH, pm perimesencephalic SAH, DCI delayed cerebral ischemia, CSF cerebrospinal fluid, VP ventriculoperitoneal, mRS modified Rankin Scale. ANOVA/Kruskal–Wallis test/chi-square as appropriate. For multiple comparisons, please see the supplementary material
| Parameter | aSAH | npm SAH | pmSAH | p-value |
|---|---|---|---|---|
| DCI [n] | 44 (38.3%) | 7 (36.8%) | 1 (6.25%) | 0.041 |
| DCI-related infarction [n] | 18 (15.7%) | 2 (10.5%) | 0 (0%) | 0.2095 |
| Any infarction [n] | 48 (43.6%) | 4 (21.1%) | 0 (0%) | 0.0011 |
| Acute hydrocephalus [n] | 76 (66.1%) | 14 (73.7%) | 0 (0%) | < 0.0001 |
| Need for permanent CSF diversion (VP shunt) [n] | 21 (18.3%) | 5 (26.3%) | 0 (0%) | 0.106 |
| Length of stay [d] | 21 [17–35] | 19 [14–29] | 8 [6–10] | < 0.0001 |
| In-house mortality [n] | 14 (12.2%) | 1 (5.3%) | 0 (0%) | 0.173 |
| mRS 0–2 at 6mo [n] | 64/102 (62.7%) | 15/18 (83.3%) | 13/14 (92.9%) | 0.0264 |